| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 130 |
| 1 | INFLIXIMAB | 70 |
| 2 | METHOTREXATE SODIUM | 69 |
| 3 | METHOTREXATE | 67 |
| 4 | VEDOLIZUMAB | 65 |
| 5 | AZATHIOPRINE | 48 |
| 6 | SULFASALAZINE | 45 |
| 7 | PREDNISONE | 42 |
| 8 | ADALIMUMAB-ADAZ | 38 |
| 9 | ADALIMUMAB-AATY | 33 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DYCLONINE HYDROCHLORIDE | 1 | 0.0105 |
| 1 | INFLIXIMAB-DYYB | 16 | 0.0046 |
| 2 | BERBERIS VULGARIS, ISATIS TINCTORIA, MORINDA CITRIFOLIA, PETIVERIA TETRANDRA, SCHINUS MOLLE, THYMOLUM, UVA-URSI | 1 | 0.0034 |
| 3 | SODIUM PICOSULFATE, MAGNESIUM OXIDE, AND ANHYDROUS CITRIC ACID | 2 | 0.0028 |
| 4 | ORPHENADRINE CITRATE | 1 | 0.0016 |
| 5 | DARIFENACIN HYDROBROMIDE | 1 | 0.0012 |
| 6 | ADALIMUMAB-AFZB | 3 | 0.0011 |
| 7 | IOPAMIDOL | 3 | 0.0010 |
| 8 | MESALAMINE | 28 | 0.0010 |
| 9 | OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE | 1 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 120 |
| 1 | Corticosteroid [EPC] | 74 |
| 2 | Aminosalicylate [EPC] | 67 |
| 3 | Integrin Receptor Antagonist [EPC] | 67 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 66 |
| 5 | Purine Antimetabolite [EPC] | 48 |
| 6 | Interleukin-23 Antagonist [EPC] | 38 |
| 7 | Interleukin-12 Antagonist [EPC] | 33 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 29 |
| 9 | Vitamin B12 [EPC] | 24 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Integrin Receptor Antagonist [EPC] | 67 | 0.0008 |
| 1 | Aminosalicylate [EPC] | 67 | 0.0007 |
| 2 | Anti-coagulant [EPC] | 2 | 0.0005 |
| 3 | Purine Antimetabolite [EPC] | 48 | 0.0005 |
| 4 | Provitamin D2 Compound [EPC] | 14 | 0.0005 |
| 5 | Bile Acid Sequestrant [EPC] | 5 | 0.0004 |
| 6 | Interleukin-23 Antagonist [EPC] | 38 | 0.0004 |
| 7 | Interleukin-12 Antagonist [EPC] | 33 | 0.0003 |
| 8 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 66 | 0.0001 |